Pharma Focus Asia

Roswell Park Comprehensive Cancer Centre Invests US$98 million to Open Cell and Gene Therapy Hub in New York, USA

Roswell Park Comprehensive Cancer Centre invests US$98 million to open cell and gene therapy manufacturing facility in USA.

The US$98 million centre will revolutionise the field of life-saving therapies by significantly enhancing research and development capabilities. Moreover, this facility will serve as a catalyst for the expansion of the cell and gene therapy sector.

This state-of-the-art facility expands the existing cell and gene therapy research capacity at Roswell's Therapeutic Cell Production Facility, from six to 20 specialised clean rooms making it now the largest academic cell and gene therapy research and manufacturing facility in the United States.

The new facility is set to optimise the entire cell therapy development pipeline, significantly reducing the time from research to production. In addition, it will help to develop and sell new therapies, bring in talented people focuisng on innovation.

The new facility aims to develop groundbreaking treatments with the potential to improve the outcomes for individuals fighting cancer.

Name    Roswell Park Comprehensive Cancer Center
Type      New Construction
Budget   US$98 million

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Thermo Fisher Scientific - Rapid Mycoplasma TestingAsia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024Medlab Middle East 2024ISPE Singapore Affiliate Conference & Exhibition 2024